Yahoo

The FDA Just Cleared the Dexcom G7 15-Day, the Longest-Lasting CGM

The US Food and Drug Administration has cleared the Dexcom G7 15-Day Continuous Glucose Monitor (CGM) for people older than 18 with diabetes. It's the longest-lasting system on the market. The G7 ...
zacks

DXCM Stock Falls as FDA Warnings Raise Concern for 15-Day G7 Approval

Based on page view growth over the last 3 trading days DexCom (DXCM Quick Quote DXCM - Free Report) is facing regulatory scrutiny following a warning letter recently posted by the FDA. This could ...
CNET

The FDA Just Cleared the Dexcom G7 15-Day, the Longest-Lasting CGM Wearable

The new sensor — expected to launch in the second half of 2025 — will provide easier diabetes management for eligible users. Taylor Leamey wrote about all things wellness for CNET, specializing in ...
Nasdaq

DXCM Stock Falls as FDA Warnings Raise Concern for 15-Day G7 Approval

DexCom DXCM is facing regulatory scrutiny following a warning letter recently posted by the FDA. This could affect the approval of the company’s upcoming 15-day G7 continuous glucose monitor (CGM).